RESUMO
OBJECTIVE: To establish a quality indicator for pharmaceutical care in an integral system for personalized medication dispensing (ISPMD) with electronic prescription. METHODS: Descriptive transversal study. PERIOD: 2007. On a daily basis, we revised the pharmaceutical treatment of patients admitted to hospital units with ISPMD. STUDY VARIABLES: a) suitability of pharmaceutical interventions: important or very important; b) acceptance of those interventions. The LASER method was used to identify patients with improvement opportunities. RESULTS: In absolute terms (mean +/- SD): important pharmaceutical interventions, 26.6 +/- 14.8; very important, 31.5 +/- 24.6; acceptance, 57.5 +/- 25.9. Percentages (95 % CI): pharmaceutical interventions: important, 33.7 (9.3-58.0); very important, 39.80 (17.7-62.2); acceptance, 72.6 (64.7-80.5). CONCLUSIONS: Implementation of the quality indicator for pharmaceutical care allowed us to evaluate the clinical significance and the acceptance rate of the pharmaceutical care being provided.
Assuntos
Prescrição Eletrônica/normas , Sistemas de Medicação no Hospital/normas , Serviço de Farmácia Hospitalar/normas , Indicadores de Qualidade em Assistência à Saúde , Adulto , Sistemas de Notificação de Reações Adversas a Medicamentos/organização & administração , Sistemas de Notificação de Reações Adversas a Medicamentos/normas , Estudos Transversais , Feminino , Controle de Formulários e Registros , Humanos , Masculino , Erros de Medicação/prevenção & controle , Pessoa de Meia-Idade , Aceitação pelo Paciente de Cuidados de Saúde , Serviço de Farmácia Hospitalar/organização & administração , Encaminhamento e Consulta/organização & administração , Adulto JovemRESUMO
Objetivo: Establecer un indicador de calidad de atención farmacéutica en un centro con sistema integral de dispensación individualizada de medicación (SIDIM) y prescripción electrónica. Métodos: Estudio descriptivo transversal. Periodo: año 2007. Se realizó una revisión diaria del tratamiento farmacoterapéutico de los pacientes ingresados en unidades de hospitalización con SIDIM. Variables de estudio: a) idoneidad de las intervenciones farmacéuticas: importantes, muy importantes, y b) aceptación de éstas. Para la identificación de pacientes con oportunidades de mejora en su farmacoterapia se empleó la metodología LASER®. Resultados: En términos absolutos (media ± desviación estándar): intervenciones farmacéuticas importantes, 26,6 ± 14,8; muy importantes, 31,5 ± 24,6; aceptación, 57,5 ± 25,9. En porcentaje (intervalo de confianza del 95 %): intervenciones farmacéuticas importantes, 33,7 (9,3-58,0); muy importantes, 39,80 (17,7-62,2); aceptación, 72,6 (64,7-80,5). Conclusiones: La implantación del indicador de calidad de atención farmacéutica ha permitido evaluar la significación clínica y el grado de aceptación de las intervenciones farmacéuticas realizadas (AU)
Objective: To establish a quality indicator for pharmaceutical care in an integral system for personalised medication dispensing (ISPMD) with electronic prescription. Methods: Descriptive transversal study. Period: 2007. On a daily basis, we revised the pharmaceutical treatment of patients admitted to hospital units with ISPMD. Study variables: a) suitability of pharmaceutical interventions: important or very important; b) acceptance of those interventions. The LASER® method was used to identify patients with improvement opportunities. Results: In absolute terms (mean ± SD): important pharmaceutical interventions, 26.6 ± 14.8; very important, 31.5 ± 24.6; acceptance, 57.5 ± 25.9. Percentages (95 % CI): pharmaceutical interventions: important, 33.7 (9.3-58.0); very important, 39.80 (17.7-62.2); acceptance, 72.6 (64.7-80.5). Conclusions: Implementation of the quality indicator for pharmaceutical care allowed us to evaluate the clinical significance and the acceptance rate of the pharmaceutical care being provided (AU)